PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsgraft vs host disease
MeSH D006086 - graft vs host disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007154:Immune system diseases
$
Success rate
D006086: 
Graft vs host disease
D000092122:Bronchiolitis obliterans syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMethylprednisolone Methylprednisolone  2006-10-27   
Mycophenolate mofetil Mycophenolate Mofetil  2009-05-04   
Mycophenolate mofetil Mycophenolate mofetil Teva  2008-02-21   
Mycophenolate mofetil Myfenax  2008-02-21   
Prednisone Prednisone  1982-01-01   
Tacrolimus Tacforius  2017-12-08   
Novast LaboratoriesMethylprednisolone Methylprednisolone  2019-01-09   
Glenmark PharmaceuticalsTacrolimus Tacrolimus  2020-11-10   
LEO PharmaTacrolimus Protopic  2000-12-08   
MylanMycophenolate mofetil Mycophenolate Mofetil  2009-05-04   
Prednisone Prednisone  1982-01-01   
Tacrolimus Tacrolimus  2010-09-17   
RocheMycophenolate mofetil CellCept  1995-05-03 $492.312 M Q4/22-Q3/23 
Daclizumab Zenapax  1997-12-10   
SandozMethylprednisolone Methylprednisolone  1997-10-31   
Mycophenolate mofetil Mycophenolate Mofetil  2008-10-15   
Tacrolimus Tacrolimus  2009-08-10   
AiPing PharmaceuticalPrednisone Prednisone  1982-01-01   
OrganonMethylprednisolone Methylprednisolone  1982-06-25   
NovartisRuxolitinib Jakavi  2012-08-23 $1,702 M Q2/21-Q2/24 
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
81%
67/83
Phase 2
39%
47/119
Phase 3
47%
29/62
Approved: 9Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use